Table: Rohto -2023/24 group results

Rohto Pharmaceutical

13/05/2024 07:00

May 13 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            270.84          238.66         300.00                 
                 (+13.5 pct)     (+19.5 pct)    (+10.8 pct)              
  Operating         40.05           33.96          43.00                 
                 (+17.9 pct)     (+17.0 pct)    (+7.4 pct)               
  Recurring         42.43           35.57          44.00                 
                 (+19.3 pct)     (+23.7 pct)    (+3.7 pct)               
  Net
  Net               30.94           26.38          32.00                 
                 (+17.3 pct)     (+24.9 pct)    (+3.4 pct)               
  EPS            135.61 yen      115.62 yen     140.27 yen               
  EPS Diluted    135.21 yen      115.29 yen                              
  Ann Div         27.00 yen                      30.00 yen               
  -Q2 Div         12.00 yen       20.00 yen      15.00 yen               
  -Q4 Div         15.00 yen       12.00 yen      15.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T